Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

 
   Single User - $995
   Corporate License - $1,990
   Online Download plus 1 Hard Copy - $4,295



Loading...
Published Feb 1, 2008 | 250+ Pages | Pub ID: KLI1638430

Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients have developed dilated cardiomyopathy, which is the final common pathway for many cardiac illnesses and a common cause of congestive heart failure.

Kalorama Information's Congestive Heart Failure, Major World Markets series looks at markets for CHF treatment in the United States, Europe, Japan and the Rest of the World. Volume II of this series looks at markets for device management of this disease in the following key categories:

  • Pacemakers
  • Left Ventricular Assistance Devices (LVADs)
  • Implantable Cardioverter/Defibrillators (ICDs)
  • Artificial Hearts
The report offers revenue breakdowns the following world markets:
  • US
  • Europe
  • Japan
  • Rest of World
In addition to market forecasts and current market information, this report contains a thorough review of products available on the market and profiles of key companies, including:
  • Abbott Laboratories
  • Abiomed, Inc.
  • Ambu, USA
  • Aortech International, plc
  • Arrow International
  • Atrium Medical Corporation
  • ATS Medical, Inc.
  • Bacchus Vascular, Inc.
  • Berlin Heart AG
  • Biophan Technologies, Inc.
  • Biosensors International
  • Biotronik, Inc.
  • Boston Scientific
  • CardiacAssist, Inc.
  • Cardiac Science Corporation
  • Cardiogenesis Corporation
  • Cordis Corporation/Biologics Delivery Systems
  • CoreValve, Inc.
  • CryoCath Technologies, Inc.
  • Cryocor, Inc.
  • Datascope
  • Defibtech, LLC
  • Deltex Medical
  • Heartlab
  • Impulse Dynamics USA, Inc.
  • MedicalCV, Inc.
  • Medtronic, Inc.
  • Orqis Medical Corporation
  • Sorin SpA
  • Stereotaxis, Inc.
  • St. Jude Medical, Inc.
  • Teleflex Medical
  • Terumo Heart, Inc.
  • Thoratec Corporation
  • Ventracor, Inc.
  • Volcano Corporation
As part of Kalorama Information's methodology, analyst estimates are computed with intensive research of secondary data and literature, and primary research involving interviews of experts are used to test assumptions and validate models.

Product managers, business development executives, marketing executives and planners are among those who will benefit from this resource.

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.

In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.